A topical otic solution combining a local anesthetic (Benzocaine), an antiseptic/analgesic (Chlorbutol), an insecticidal agent (Paradichlorobenzene), and a counterirritant (Turpentine Oil). It is primarily indicated for the symptomatic relief of earache associated with otitis externa and for the management of ear canal myiasis (fly/maggot infestation). The formulation provides rapid analgesic, anti-inflammatory, antiseptic, and insecticidal action.
Adult: Instill 2-3 drops into the affected ear canal 2-3 times daily, or as directed by the physician. For myiasis, the ear canal may be packed with a cotton wick soaked in the solution.
Note: 1. Warm the bottle in hands for a minute. 2. Lie on side with affected ear up. 3. Pull the outer ear backward and upward (adults) or backward and downward (children) to straighten the canal. 4. Instill prescribed drops. 5. Remain in position for 5 minutes. 6. Insert a clean cotton plug if advised. 7. Avoid touching dropper tip to ear or any surface. Use only for the ear. Do not use if solution is discolored or contains particles.
The combination exerts a multi-modal action. Benzocaine blocks sodium channels on neuronal membranes, preventing initiation and conduction of nerve impulses (pain signals). Chlorbutol provides mild local anesthetic and antiseptic properties, reducing microbial load and inflammation. Paradichlorobenzene acts as a fumigant insecticide, killing larvae (maggots) and repelling flies through its volatile vapor. Turpentine Oil acts as a counterirritant and rubefacient, causing mild irritation and vasodilation, which may provide a sensation of warmth and distract from deeper pain.
Pregnancy: Category C: Animal reproduction studies have not been conducted. Not recommended during pregnancy unless the potential benefit justifies the potential risk to the fetus. Systemic absorption is minimal, but components like paradichlorobenzene are potentially toxic.
Driving: May cause transient dizziness or vertigo immediately after instillation. Patients should not drive or operate machinery until they are sure they are not affected.
| Sulfonamide antibiotics (e.g., Cotrimoxazole) | Benzocaine metabolizes to PABA, which may antagonize the antibacterial effect of sulfonamides. | Moderate |
| Other topical otic preparations (e.g., antibiotic-steroid drops) | Physical/chemical incompatibility. Should not be instilled simultaneously; wait at least 30 minutes between applications. | Moderate |
| Cholinesterase inhibitors (e.g., Neostigmine, Pyridostigmine) | Theoretical: Benzocaine hydrolysis may be altered. Clinical significance is low with topical use. | Low |